Healthcare -
Biotechnology - NASDAQ - US
$ 243.34
-1.38 %
$ 31.5 B
Market Cap
-112.14
P/E
ALNY - RETAINED EARNINGS
Retained Earnings ALNY - Alnylam Pharmaceuticals, Inc.
0
LAST VALUE
41.42%
2 YEAR CAGR
14.87%
5 YEAR CAGR
7.18%
10 YEAR CAGR